Erste Group upgraded AbbVie (ABBV) to Buy from Hold.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie announces final analysis of Phase 3 MIRASOL trial
- Big Pharma rejoins the mental health field, WSJ says
- AbbVie: Hold Rating Maintained Amid Strong Skyrizi Sales and Valuation Concerns
- AbbVie price target raised to $195 from $165 at Berenberg
- Biotech Alert: Searches spiking for these stocks today
Questions or Comments about the article? Write to editor@tipranks.com